tiprankstipranks
Advertisement
Advertisement

PSTV Stock Latest News

Plus Therapeutics Regains Nasdaq Listing Compliance After Reverse Split
Company AnnouncementsPlus Therapeutics Regains Nasdaq Listing Compliance After Reverse Split
11d ago
8K
PSTV
Plus Therapeutics regains compliance with Nasdaq minimum bid price requirement
PremiumThe Fly
Plus Therapeutics regains compliance with Nasdaq minimum bid price requirement
11d ago
PSTV
PSTV Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
PSTV Upcoming Earnings Report: What to Expect?
18d ago
PSTV
Plus Therapeutics Appoints New Chief Development Officer
PremiumCompany Announcements
Plus Therapeutics Appoints New Chief Development Officer
23d ago
8K
PSTV
Plus Therapeutics appoints Eric Daniels as chief development officer
PremiumThe Fly
Plus Therapeutics appoints Eric Daniels as chief development officer
23d ago
PSTV
Plus Therapeutics Gains FDA Orphan Status for REYOBIQ
PremiumCompany AnnouncementsPlus Therapeutics Gains FDA Orphan Status for REYOBIQ
24d ago
8K
PSTV
Plus Therapeutics granted Orphan Drug Designation for Reyobiq
Premium
The Fly
Plus Therapeutics granted Orphan Drug Designation for Reyobiq
24d ago
PSTV
Plus Therapeutics price target lowered to $12 from $37.50 at Maxim
Premium
The Fly
Plus Therapeutics price target lowered to $12 from $37.50 at Maxim
25d ago
PSTV
Plus CNSide Cerebrospinal Fluid Tumor Cell Enumeration test gets AMA PLA code
PremiumThe Fly
Plus CNSide Cerebrospinal Fluid Tumor Cell Enumeration test gets AMA PLA code
25d ago
PSTV
Plus Therapeutics’ treatment of malignant glioma granted FDA orphan designation
PremiumThe Fly
Plus Therapeutics’ treatment of malignant glioma granted FDA orphan designation
26d ago
PSTV
Plus Therapeutics Enacts Reverse Stock Split to Maintain Listing
PremiumCompany Announcements
Plus Therapeutics Enacts Reverse Stock Split to Maintain Listing
30d ago
8K
PSTV
Plus Therapeutics Inc (USA) trading halted, news pending
PremiumThe Fly
Plus Therapeutics Inc (USA) trading halted, news pending
1M ago
PSTV
Plus Therapeutics downgraded to Hold from Buy at D. Boral Capital
PremiumThe FlyPlus Therapeutics downgraded to Hold from Buy at D. Boral Capital
1M ago
PSTV
Plus Therapeutics announces 1-for-25 reverse stock split
Premium
The Fly
Plus Therapeutics announces 1-for-25 reverse stock split
1M ago
PSTV
Plus Therapeutics Adds Industry Veteran Ronald Andrews to Board
Premium
Company Announcements
Plus Therapeutics Adds Industry Veteran Ronald Andrews to Board
1M ago
8K
PSTV
Plus Therapeutics’ CNSide assay may reduce healthcare costs
PremiumThe Fly
Plus Therapeutics’ CNSide assay may reduce healthcare costs
1M ago
PSTV
Plus Therapeutics: Advancing Reyobiq Pipeline and CNSide Commercialization Underpinned by Strong Cash Runway to 2027
PremiumRatings
Plus Therapeutics: Advancing Reyobiq Pipeline and CNSide Commercialization Underpinned by Strong Cash Runway to 2027
2M ago
PSTV
Plus Therapeutics Sets 2026 Virtual Annual Stockholder Meeting
PremiumCompany Announcements
Plus Therapeutics Sets 2026 Virtual Annual Stockholder Meeting
2M ago
8K
PSTV
Plus Therapeutics reports Q4 EPS (29c), consensus (4c)
PremiumThe Fly
Plus Therapeutics reports Q4 EPS (29c), consensus (4c)
2M ago
PSTV
Plus Therapeutics: AMA Code Milestone and 2026 Clinical Catalysts Underpin Buy Rating and $1 Target
PremiumRatingsPlus Therapeutics: AMA Code Milestone and 2026 Clinical Catalysts Underpin Buy Rating and $1 Target
2M ago
PSTV
Plus announces new Category III CPT code for CED used with Reyobiq
Premium
The Fly
Plus announces new Category III CPT code for CED used with Reyobiq
2M ago
PSTV
Is PSTV a Buy, Before Earnings?
Premium
Pre-Earnings
Is PSTV a Buy, Before Earnings?
2M ago
PSTV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >